2022
Modeling comparative cost-effectiveness of SARS-CoV-2 vaccine dose fractionation in India
Du Z, Wang L, Pandey A, Lim WW, Chinazzi M, Piontti APY, Lau EHY, Wu P, Malani A, Cobey S, Cowling BJ. Modeling comparative cost-effectiveness of SARS-CoV-2 vaccine dose fractionation in India. Nature Medicine 2022, 28: 934-938. PMID: 35210596, PMCID: PMC9117137, DOI: 10.1038/s41591-022-01736-z.Peer-Reviewed Original ResearchConceptsLarge-scale survey dataEconomic benefitsFull dose vaccinationSurvey dataHospital admission costsDose-sparing strategiesCost of hospitalizationCOVID-19 deathsPopulation-level transmissionVaccine dosesVaccination strategiesAdmission costsEconomic burdenVaccine shortageFractional dosesVaccinationDose fractionationHigh transmissibilityVaccine distributionCostPublic healthVaccineWillingnessDosesIndia
2021
Challenges facing COVID-19 vaccination in India: Lessons from the initial vaccine rollout
Pandey A, Sah P, Moghadas SM, Mandal S, Banerjee S, Hotez PJ, Galvani AP. Challenges facing COVID-19 vaccination in India: Lessons from the initial vaccine rollout. Journal Of Global Health 2021, 11: 03083. PMID: 34221355, PMCID: PMC8243816, DOI: 10.7189/jogh.11.03083.Peer-Reviewed Original ResearchOptimal COVID-19 quarantine and testing strategies
Wells CR, Townsend JP, Pandey A, Moghadas SM, Krieger G, Singer B, McDonald RH, Fitzpatrick MC, Galvani AP. Optimal COVID-19 quarantine and testing strategies. Nature Communications 2021, 12: 356. PMID: 33414470, PMCID: PMC7788536, DOI: 10.1038/s41467-020-20742-8.Peer-Reviewed Original Research
2020
The implications of silent transmission for the control of COVID-19 outbreaks
Moghadas SM, Fitzpatrick MC, Sah P, Pandey A, Shoukat A, Singer BH, Galvani AP. The implications of silent transmission for the control of COVID-19 outbreaks. Proceedings Of The National Academy Of Sciences Of The United States Of America 2020, 117: 17513-17515. PMID: 32632012, PMCID: PMC7395516, DOI: 10.1073/pnas.2008373117.Peer-Reviewed Original ResearchConceptsSilent infectionSymptomatic casesAsymptomatic transmissionSilent transmissionPopulation-wide restrictionsRisk of resurgenceRapid contact tracingRecent individual-level dataCoronavirus disease 2019Symptom onsetAsymptomatic proportionAsymptomatic infectionDisease 2019Majority of incidencesPresymptomatic stagePresymptomatic casesInfected individualsContact tracingInfectionFuture outbreaksCOVID-19 outbreakSocial distancing measuresOne-thirdMovement restrictionsDistancing measuresImpact of international travel and border control measures on the global spread of the novel 2019 coronavirus outbreak
Wells CR, Sah P, Moghadas SM, Pandey A, Shoukat A, Wang Y, Wang Z, Meyers LA, Singer BH, Galvani AP. Impact of international travel and border control measures on the global spread of the novel 2019 coronavirus outbreak. Proceedings Of The National Academy Of Sciences Of The United States Of America 2020, 117: 7504-7509. PMID: 32170017, PMCID: PMC7132249, DOI: 10.1073/pnas.2002616117.Peer-Reviewed Original ResearchConceptsAppropriate public health responseSARS-CoV-2 casesSevere acute respiratory syndrome casesCOVID-19 outbreakImportation of casesPublic health responseInternational travelControl measuresSyndrome casesCoronavirus outbreakHealth responseGlobal spreadTravel restrictionsNovel coronavirus outbreakBorder control measuresDaily riskHalf weeksOutbreakEarly stagesCasesMainland China